Subanesthetic S-ketamine prevents postoperative delirium and reduces inflammatory cytokines in older patients receiving hip fracture surgery: a randomized, controlled study
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-025-04945-8 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Junde Hou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, the Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, China. Hauptthemen laut MEDLINE: Ketamine, Hip Fractures, Cytokines, Analgesics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Themen: Delir
Abstract (Originalsprache)
The preventive effect of S-ketamine on postoperative delirium (POD) in older patients receiving elective surgery is controversial. This randomized, controlled study aimed to evaluate the effect of subanesthetic S-ketamine on the incidence of POD in older patients receiving hip fracture surgery. Three hundred and fifty-six older patients scheduled for elective hip fracture surgery were randomized to S-ketamine group (N = 178, received S-ketamine 0.3 mg/kg loading, 0.2 mg/kg/h infusion) and control group (N = 178, received normal saline with an equal volume). The S-ketamine group showed a lower incidence of POD within 7 days than the placebo group (9.6% versus 29.8%, P < 0.001). Compared with the control group, the S-ketamine group had a lower Pittsburgh Sleep Quality Index score from the surgery day (D0) to day (D)3 after surgery (all P < 0.001). However, pain at rest and at motion (assessed by numerical rating scale) until D2, as well as patient-controlled intravenous analgesic bolus and rescue analgesic within 48 h, were not different between groups. Additionally, the S-ketamine group showed lower proinflammatory cytokines from D0 to D3, including interleukin-1β, interleukin-6, and tumor necrosis factor-α, compared with the control group (all P < 0.01). Moreover, the S-ketamine group disclosed a lower incidence of nausea and vomiting than the placebo group (6.7% versus 28.1%, P < 0.001); the other adverse reactions were comparable between the two groups. S-ketamine at a subanesthetic dose effectively prevents POD and improves sleep quality, with a good safety profile in older patients receiving hip fracture surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, the Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, China.
- Department of Anesthesiology, Handan Central Hospital, Handan, 056018, China.
- Department of Anesthesiology, the Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, China. 26501219@hebmu.edu.cn.
Zitieren
APA
Hou, J., Wang, J., Li, Y., Liu, R., & Gao, J. (2026). Subanesthetic S-ketamine prevents postoperative delirium and reduces inflammatory cytokines in older patients receiving hip fracture surgery: a randomized, controlled study. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04945-8
Vancouver
Hou J, Wang J, Li Y, Liu R, Gao J. Subanesthetic S-ketamine prevents postoperative delirium and reduces inflammatory cytokines in older patients receiving hip fracture surgery: a randomized, controlled study. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04945-8
BibTeX
@article{Hou2026,
author = {Hou, Junde and Wang, Jiaxin and Li, Yifan and Liu, Runbin and Gao, Jingui},
title = {Subanesthetic S-ketamine prevents postoperative delirium and reduces inflammatory cytokines in older patients receiving hip fracture surgery: a randomized, controlled study},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-025-04945-8}
}
EUVIMED